Angioplasty News and Research RSS Feed - Angioplasty News and Research

In angioplasty procedures, a balloon is fed through a catheter and used to prop open an artery that has become narrowed or blocked. In cases where stenting is appropriate, a stent mounted on a balloon is inserted and inflation of the balloon expands the stent against the blocked artery wall to hold the vessel open. The balloon is then deflated and the catheter is withdrawn. Stent treatment of arteries holds them open and improves blood flow to the heart. In cases where post-dilatation is needed, a high-pressure balloon is inflated inside a stent to help better place the stent against the vessel wall.
VCOR project aims to improve coronary angioplasty services in Victoria

VCOR project aims to improve coronary angioplasty services in Victoria

Victorian Hospitals will be better equipped to measure the quality of care for their cardiac patients, under a new project that collects and compares data on coronary angioplasty practice. [More]
Mount Sinai Hospital first in nation to use drug-coated balloon to open blocked arteries in the leg

Mount Sinai Hospital first in nation to use drug-coated balloon to open blocked arteries in the leg

The Mount Sinai Hospital is first in the United States to use the first and only FDA-approved, drug-coated balloon to open blocked arteries in the leg. [More]
Power grid failure inside injured cardiac cells triggers post-heart attack arrhythmias

Power grid failure inside injured cardiac cells triggers post-heart attack arrhythmias

Heart attack survivors often experience dangerous heart rhythm disturbances during treatment designed to restore blood flow to the injured heart muscle, a common and confounding complication of an otherwise lifesaving intervention. [More]
Viewpoints: Mergers causing health costs to rise; reauthorize CHIP; Obamacare's influence on politics

Viewpoints: Mergers causing health costs to rise; reauthorize CHIP; Obamacare's influence on politics

Health care costs are going up, and there's a lot of debate about why. Is it the high cost of drugs or our aging population? [More]
Calling 9-1-1 can speed access to lifesaving treatment, say cardiology researchers

Calling 9-1-1 can speed access to lifesaving treatment, say cardiology researchers

Time is critical for patients experiencing a heart attack, and calling 9-1-1 first will speed access to lifesaving treatment, according to MedStar Heart & Vascular Institute cardiology researchers. [More]
Abbott announces initiation of ABSORB IV heart stent clinical trial

Abbott announces initiation of ABSORB IV heart stent clinical trial

Abbott announced today the start of the ABSORB IV clinical trial, which will test whether its Absorb Bioresorbable Vascular Scaffold (BVS) is more cost-effective and offers a higher quality of life than a best-in-class, permanent, metallic drug eluting stent. [More]
Viewpoints: Rove renews attack on health law; Calif. 'vaccination crisis'

Viewpoints: Rove renews attack on health law; Calif. 'vaccination crisis'

The disconnect between what Americans think of most provisions of Obamacare (love them!) and what they think of "Obamacare" (hate it!) has been the most perplexing aspect of rollout of the Affordable Care Act. [More]
Complete revascularisation leads to better outcomes in patients with heart attack

Complete revascularisation leads to better outcomes in patients with heart attack

In patients being treated for heart attack, complete revascularisation of all significantly blocked arteries leads to better outcomes compared to a strategy of unblocking just the "culprit" artery responsible for the heart attack, according to a new study presented today at ESC Congress 2014. [More]
Dr. Mark Rasak recognized with Diamond Lifetime Achievement Award in the field of Medicine

Dr. Mark Rasak recognized with Diamond Lifetime Achievement Award in the field of Medicine

Dr. Mark Rasak, MD is recognized by Continental Who's Who with the Diamond Lifetime Achievement Award in the field of Medicine as a result of his role as CEO of Cardiovascular Clinical Associates. [More]
Cardium announces review in Journal of Cardiovascular Pharmacology finds gene therapy for subset of heart disease patients ‘highly warranted’

Cardium announces review in Journal of Cardiovascular Pharmacology finds gene therapy for subset of heart disease patients ‘highly warranted’

Cardium Therapeutics, an operating unit of Taxus Cardium Pharmaceuticals Group Inc. (Trading Symbol: CRXM) has announced the publication of a review article in the Journal of Cardiovascular Pharmacology that concludes a gene therapy product promoting the growth of blood vessels is “highly warranted” to treat about 1 million U.S. heart-disease patients and 6 million more worldwide who are either ineligible or poor candidates for traditional angioplasty, stent placement or bypass surgery. [More]
Cardium reports positive results from Generx Ad5FGF-4 Phase 3 study for treatment of myocardial ischemia

Cardium reports positive results from Generx Ad5FGF-4 Phase 3 study for treatment of myocardial ischemia

Taxus Cardium Pharmaceuticals Group Inc. will report today at the Biotechnology Industry Organization’s 2014 BIO International Convention on a pre-specified interim analysis from its international ASPIRE Phase 3 registration clinical study of Generx Ad5FGF-4, Cardium Therapeutics’ angiogenic gene therapy product candidate for patients with myocardial ischemia due to coronary artery disease. [More]
Study shows room for improvement in medical management of women with PAD

Study shows room for improvement in medical management of women with PAD

Women face greater limits on their lifestyle and have more severe symptoms as a result of peripheral artery disease (PAD), but minimally invasive procedures used to unclog arteries are just as successful as in men. [More]
Cardiac Catheterization Laboratory of Mount Sinai Heart receives highest "two-star" safety rating

Cardiac Catheterization Laboratory of Mount Sinai Heart receives highest "two-star" safety rating

The Cardiac Catheterization Laboratory of Mount Sinai Heart at The Mount Sinai Hospital has once again received the highest "two-star" safety rating from the New York State Department of Health for its percutaneous coronary interventions (PCI) overall and in non-emergency cases. [More]
Penn study clarifies action of potential new class of pain relievers that may benefit and not hurt heart

Penn study clarifies action of potential new class of pain relievers that may benefit and not hurt heart

Nonsteroidal antinflamatory drugs (NSAIDs) that block an enzyme called COX-2 relieve pain and inflammation but can cause heart attacks, stroke, heart failure, and even sudden cardiac death. [More]
Jersey Shore opens new CVICU to provide post-operative care for cardiac surgery patients

Jersey Shore opens new CVICU to provide post-operative care for cardiac surgery patients

Jersey Shore University Medical Center recently unveiled the new CardioVascular Intensive Care Unit (CVICU) - a twelve bed critical care unit providing post-operative care for cardiac surgery patients, including those who receive traditional open heart surgery and newer, complex interventional cardiovascular procedures. [More]
Heparin proves effective than bivalirudin in patients receiving percutaneous coronary intervention after heart attack

Heparin proves effective than bivalirudin in patients receiving percutaneous coronary intervention after heart attack

In a comparison of two blood-thinning medications, heparin was associated with significantly fewer major cardiovascular events at 28 days than bivalirudin in patients receiving primary percutaneous coronary intervention after a heart attack, according to research presented at the American College of Cardiology's 63rd Annual Scientific Session. [More]
Corindus Vascular Robotics to showcase FDA-cleared CorPath System at ACC annual meeting

Corindus Vascular Robotics to showcase FDA-cleared CorPath System at ACC annual meeting

Corindus Vascular Robotics, the leader in precision vascular robotics, will showcase its FDA-cleared CorPath System at the upcoming American College of Cardiology annual meeting, March 29 – 31 in Washington, D.C. [More]
CSI's new Diamondback Peripheral 60cm systems receive FDA clearance for PAD treatment

CSI's new Diamondback Peripheral 60cm systems receive FDA clearance for PAD treatment

Cardiovascular Systems, Inc., announced today it has received FDA clearance of its new Diamondback 360 60cm Peripheral Orbital Atherectomy Systems (OAS) for the treatment of peripheral arterial disease (PAD). [More]
Report highlights benefits of different access approach to treat uterine fibroids

Report highlights benefits of different access approach to treat uterine fibroids

Interventional radiologists have devised a new way to access a woman's fibroids-by flipping her wrist and treating via an arm not groin artery-to nonsurgically shrink noncancerous growths in the muscular wall of the uterus. Researchers found this to be less painful and traumatic for women, allowing them to immediately sit up and move after uterine fibroid embolization (UFE)-with no overnight stay, according to a March article in the Society of Interventional Radiology's flagship publication, the Journal of Vascular and Interventional Radiology. [More]
Long-term risks of deep vein thrombosis

Long-term risks of deep vein thrombosis

Deep vein thrombosis (DVT) often brings with it the risk of post-thrombotic syndrome (PTS), an under-recognized but serious complication that often causes long-term disability for patients. During March's DVT Awareness Month, the Society of Interventional Radiology wants to help patients and family members to better understand the long-term risks of DVT. [More]